Most irAEs-associated deaths are induced by colitis in patients treated with anti-CTLA-4, while pneumonitis, hepatitis, and neurotoxicity are the main cause of death in patients in whom the PD-1/PD-L1 axis is inhibited [12]. The gene discussed is CD274; the disease is pneumonitis.